How to Use This Comparison Tool
The GLP-1 Telehealth Provider Comparison shows every major self-pay GLP-1 provider in one place, filtered by what matters most to your situation. The market has changed significantly in 2026 — Hims exited the compounded GLP-1 space after FDA warning letters, Ro pivoted to brand-name-only drugs, and the oral Wegovy pill launched in January 2026 through NovoCare and Ro. This comparison reflects the current market as of May 2026, not the 2024 landscape most comparison articles still describe.
Use the drug type filter first — semaglutide, tirzepatide, oral/pill, or brand-name only. This is the most important variable because it narrows your options significantly. If you want an oral pill rather than an injection, only three providers offer that option right now. The budget filter shows only providers whose starting price falls within your range. The features filter lets you narrow by HSA acceptance, insurance billing, no-contract terms, or flat pricing across all doses.
One critical warning about comparison shopping in this market: advertised prices almost always reflect starter doses, not maintenance doses. A provider advertising $99 per month for compounded semaglutide may charge $199 or $299 at the 1mg or 2.4mg maintenance dose that most patients reach within 3 to 6 months. The only providers in this comparison that publicly commit to flat pricing across all dose levels are TrimRx ($99 semaglutide / $125 tirzepatide) and LillyDirect ($299 Zepbound vials regardless of dose). Ask any provider explicitly about their maintenance-dose pricing before you commit.
What Changed in 2026
The compounded GLP-1 telehealth market underwent a major restructuring in early 2026. The FDA issued warning letters to more than 30 compounding pharmacies and telehealth platforms in the first quarter, citing concerns about manufacturing practices and marketing claims. Hims & Hers — previously one of the largest compounded GLP-1 platforms — exited the compounded market entirely and no longer offers compounded semaglutide or tirzepatide. Ro made a similar pivot, transitioning to brand-name-only medications.
For patients, this restructuring has a practical consequence: the number of legitimate, compliant compounded GLP-1 providers has narrowed. The platforms that remain — Henry Meds, MEDVi, TrimRx, and Found — are those that maintained 503A pharmacy partnerships and LegitScript certification through the enforcement period. This does not mean compounded GLP-1s are unavailable or unsafe, but it does mean the verification steps — confirming 503A or 503B registration and requesting a certificate of analysis — are more important than ever.
Brand-Name vs. Compounded: Which Should You Choose?
The honest answer is that it depends on your specific situation, and the financial case is no longer as one-sided as it was in 2024. Brand-name Wegovy at $349 per month through NovoCare is now only $200 per month more than the cheapest compounded semaglutide at $149 per month — a gap that narrows further when you factor in LillyDirect's Zepbound at $299 per month. For patients on Medicare starting July 2026, brand-name Wegovy through the Bridge program costs $50 per month, making it substantially cheaper than any compounded option.
If you are not on Medicare and are self-paying, the three most important questions are: Does your prescriber accept that the compounded formulation is clinically appropriate? Is the pharmacy 503A or 503B registered? And is the maintenance-dose price the same as the starter-dose price? If the answer to all three is yes, compounded can be a sound financial choice. If you cannot confirm the pharmacy's registration status, you should choose a brand-name option regardless of the price difference.
The Hidden Cost: What Most Comparisons Miss
Several costs consistently get missed in provider comparisons. First, billing cycles: most telehealth platforms bill every 28 days rather than monthly — this means 13 charges per year, not 12, making the real annual cost about 8% higher than the advertised monthly price. Second, lab work: most GLP-1 programs require periodic metabolic panels and A1C testing that are not included in the platform subscription — budget $100 to $300 per year for labs if your primary care provider does not cover them. Third, membership fees stacked on medication: Ro's total cost is the membership ($149/month ongoing) plus the medication cost ($199 to $349) — a combined $348 to $498 per month that looks very different from the $149 membership-only price that appears in some comparisons.
All prices shown on this page are verified from provider websites as of May 2026. Telehealth GLP-1 pricing changes frequently — we recommend confirming current pricing directly on each provider's website before enrolling. To stack tax savings on whichever option you choose, use our HSA/FSA Tax Savings Calculator, and to see how telehealth costs compare against your insurance options, use our True Monthly Cost Calculator.
Sources: Provider websites verified May 2026 (TrimRx, Henry Meds, MEDVi, Found, Ro, LillyDirect, NovoCare), Telehealth Ally GLP-1 Cost by Provider Guide April 2026, Medical Foundation of NC provider comparison April 2026, Trimi Health pricing comparison April 2026, PeptideDeck cheapest GLP-1 guide April 2026, PlexusDx cash-pay comparison May 2026. GLP1Cost.ai is not affiliated with any provider listed and earns no commission from provider links. All prices are subject to change without notice. This content is for informational purposes only and does not constitute a recommendation of any specific provider or treatment.